Bactiguard AB’s Post

Artificial Wound Fluid (Exudate) Biochemazone™ offers Artificial Wound Fluid Exudate (BZ292) to support advanced in vitro research in wound healing, infection control, and medical device testing. This ready-to-use sterile solution mimics the composition and behavior of real wound exudates, making it an indispensable tool for scientific exploration. 📌 Key Features: pH: 7.5 (Customizable as per project needs) Pack Sizes: 100 mL, 200 mL, 500 mL, 1000 mL Shelf Life: 6 months Storage: Store at 2-8℃; transportable at room temperature Take your research further with precision-engineered solutions tailored for innovation. Learn more: https://lnkd.in/gqU2GVfB #Biochemazone #WoundHealingResearch #ArtificialFluids #BiomedicalInnovation #InVitroTesting

Transforming Lives: Catheter-Acquired Urinary Tract Infections (CAUTIs) In our Transforming Lives series, we’re sharing how our innovations address pressing healthcare challenges worldwide. Catheter-Acquired Urinary Tract Infections (CAUTIs) are the most common hospital-acquired infections, with healthcare costs reaching up to £500 million per year in the UK. To combat this, 3P developed a patented Urinary Catheter Valve, using a unique valve technology allowing the bladder to fill and empty more naturally. Laboratory trials have shown this technology reduces infection rates by up to 50%. Through an NHS-funded initiative, our engineers brought this concept to clinical application, with the potential to significantly reduce patient risks and healthcare costs. Learn more about our work here: https://bit.ly/4fAt77C

Tectonic and therapeutic keratoplasties part 2: fungal keratitis can be very challenging to treat. Those aggressive infections which don’t respond to intensive anti-fungal treatment and continue to spread, threatening to reach the sclera, need a therapeutic keratoplasty, frequently a large size one, including some scleral margin. This is only the first step to control the infection; postoperative medical management to avoid recurrences is key and often challenging. I’ll be sharing tips for this and other tectonic keratoplasties during our course at the ESCRS 2024 meeting. #cornea #cornealgraft #cornealtransplant OCL Vision.

🧪 FAQ: Why do manufacturers of catheter lock solutions mix their solutions? Manufacturers combine products like citrate, heparin, and taurolidine to address the 'Triple Threat'—the challenge of preventing thrombosis, infection, and biofilm formation in catheter management. These combination products tend to be more effective than standalone solutions, as they target multiple issues simultaneously. However, it's important to note that none of these solutions can fully eradicate biofilm, which remains a persistent challenge in vascular access care. Understanding the science behind these formulations is essential for healthcare professionals in optimizing patient care. For more insights on catheter lock solutions, visit sterilecareinc.com. #CatheterCare #InfectionPrevention #HealthcareInnovation #PatientSafety #KiteLock4%

MolecuLight is an essential tool for a more inclusive and equitable wound care practice. Our technology bridges the diagnostic gap in infection assessment between light and dark skin tones, while proudly improving bacterial detection by up to 12 times higher than standard clinical assessment.     As detailed in a newly published article by Charles Andersen and colleagues, signs of infection that would be readily detected on light skin tones are often missed during clinical examination of dark skin. This delays treatment, leaving time for infection to escalate resulting in poor outcomes.    By using MolecuLight to detect and remove infection-causing bacteria in a timely manner, you can help transform wound outcomes for patients in racial/ethnic minority groups.     Want to learn more? Pop a comment in the chat or send us a message and we’ll happily connect you with a MolecuLight representative.   #MolecuLight #HealthEquity #BridgeTheGap #HealthcareInnovation   #SkinSubstitutes #InfectionPrevention #CAMPS #CellularTissueProducts 

Check out the latest SMSNA TL;DR on "Penile Prostheses Harbor Biofilms Driven by Individual Variability and Manufacturer Even in the Absence of Clinical Infection" with Juan J. Andino, MD, MBA and Raevti Bole, MD! View the full video: https://lnkd.in/e6-sc3zp *Video represents opinions of speakers.

"The Clinical Triad: Bacteremias, CAUTIs, and Skin/Soft Tissue Infections" Don't miss this exciting talk at the CT ACP Annual Scientific Meeting 2024. #ctacp24 Dive deep into: • Latest guidelines on managing catheter-associated UTIs • Strategies to reduce multidrug-resistant bacteremia • Evidence-based approaches to skin/soft tissue infections Stay ahead of the curve in infection management! This talk will equip you with practical knowledge to enhance patient care and improve outcomes. #internalmedicine #bacteremia #catheterassociatedurinarytractinfection #cme #skinandsofttissueinfection Yale School of Medicine Yale University UConn Health American College of Physicians

In a world where the demand for effective wound healing applications is exponentially increasing, the tissue engineering field opens doors to more advanced wound dressings, rapid healing and infection prevention. Remediating wound care is also highly prioritized especially in patients with diabetic foot ulcers. Most wound care programs do not fully address the possibility of microbial contamination. Find out how 3DBioFibR Inc. helps to address the above concerns with collagen-based scaffold offering. i) In a study by Wang et al. they evaluate wound healing using a full-thickness skin defect model. Their findings suggest that non-crosslinked collagen-based composite dressings hold promise for efficient wound healing applications, offering potential benefits for clinical use! https://lnkd.in/gqcfJfhv ii) In a paper by Matthew McGrath et al., they presented an innovative approach which involves the application of antimicrobial collagen-based scaffold to tackle wound repair process and to accelerate healing! https://lnkd.in/g8eUnnR9 Sciencewerke Pte Ltd #woundhealing #woundcare #wounddressing #collagenbasedscaffold #compositedressing #antimicrobialcollagenbasedscaffold #acceleratehealing #3dbiofibr

🔍 How does DEBRICHEM® compare to standard care in boosting wound healing probabilities? 🤔 According to a study by Guest et al. (2022) published in the Journal of Wound Care, patients treated with DEBRICHEM® plus standard care (SC) showed a healing probability of 0.61 by 12 months, compared to 0.35 among those treated with SC alone. Delve into the details of this article to discover how DEBRICHEM® is revolutionising wound care management. The article is free to read via the link in the comments. Curious to learn how DEBRICHEM® could impact healing outcomes for your patients? Visit our website, www.debx-medical.com, to get in touch! #DEBRICHEM #DEBxMedical #WoundHealing #biofilm #infection

ICYMI: #VisualAbstract: Low-Dose Amoxicillin is Non-Inferior to High-Dose Amoxicillin in Treating Helicobacter Pylori Infection #StudyGraphics #amoxicillin